BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37031427)

  • 1. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
    de Ligt KM; Aaronson NK; Liegl G; Nolte S;
    Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
    Young T; Velikova G; Liegl G; Rose M; Nolte S;
    Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
    Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
    Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
    Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
    Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC QLQ-C30 general population normative data for the United States.
    Rogge AA; Liegl G; Snyder C; Rose M; Nolte S;
    Eur J Cancer; 2024 May; 202():114030. PubMed ID: 38552543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
    Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
    J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.
    Mols F; Husson O; Oudejans M; Vlooswijk C; Horevoorts N; van de Poll-Franse LV
    Acta Oncol; 2018 Oct; 57(10):1381-1391. PubMed ID: 29912607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.
    Lidington E; Giesinger JM; Janssen SHM; Tang S; Beardsworth S; Darlington AS; Starling N; Szucs Z; Gonzalez M; Sharma A; Sirohi B; van der Graaf WTA; Husson O
    Qual Life Res; 2022 Sep; 31(9):2717-2727. PubMed ID: 35476170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45.
    Åsberg RE; Nilsen M; Hjermstad MJ; Reinertsen KV; Karlsen J; Giskeødegård GF; Reidunsdatter RJ
    Eur J Cancer; 2023 Sep; 190():112943. PubMed ID: 37515905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity.
    Juul T; Petersen MA; Holzner B; Laurberg S; Christensen P; Grønvold M
    Qual Life Res; 2014 Oct; 23(8):2183-93. PubMed ID: 24676897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
    Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
    Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
    Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
    Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
    Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.